Transaction Size: |
SEK 25m |
Company Name: |
Bawat Water Technologies AB |
Closing: |
August 2024 |
Investor: |
Friheden Invest, Bebop & Rocksteady and Banyan Tree Holding |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor and Bookrunner to Bawat Water Technologies AB (Publ.) in their directed new share issue |
Transaction Size: |
DKK 17.1m |
Company Name: |
Cessatech A/S |
Closing: |
January 2024 |
Investor: |
Broad range of investors |
TC Advisory: |
Translution Capital acted as Financial Advisor to Cessatech A/S (Publ.) in a TO2 warrant exercise |
Transaction Size: |
NA |
Company Name: |
idpeople A/S |
Closing: |
January 2024 |
Acquirer: |
exceet Card Group GmbH |
TC Advisory: |
Translution Capital acted as Financial Advisor to the selling shareholders of idpeople A/S on the trade sale of the company |
Transaction Size: |
NA |
Company Name: |
MME Nordic A/S |
Closing: |
June 2023 |
Acquirer: |
Blue Equity |
TC Advisory: |
Translution Capital acted as Financial Advisor to Blue Equity in connection with the add-on acquisition of the MedTech company MME Nordic A/S |
Transaction Size: |
DKK 14.7m |
Company Name: |
Cessatech A/S |
Closing: |
November 2022 |
Investor: |
Broad range of investors |
TC Advisory: |
Translution Capital acted as Financial Advisor to Cessatech A/S (Publ.) in a secured rights issue |
Transaction Size: |
DKK 108m |
Company Name: |
Medtrace Pharma A/S |
Closing: |
May 2022 |
Investor: |
ATP, BankInvest and Swisscanto |
TC Advisory: |
Translution Capital acted as Financial Advisor to Medtrace Pharma A/S in relation to their tranche II capital raise led by ATP, BankInvest and Swisscanto |
Transaction Size: |
SEK 56.7m |
Company Name: |
Bawat Water Technologies AB |
Closing: |
March 2022 |
Investor: |
Private and institutional investors |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to Bawat Water Technologies AB in their IPO to private and institutional investors |
Transaction Size: |
NA |
Company Name: |
Moscord Pte.Ltd |
Closing: |
February 2022 |
Investor: |
Consortium of international institutional and strategic investors |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to Moscord Pte.Ltd in securing their new funding round |
Transaction Size: |
NA |
Company Name: |
I Am Drinks ApS |
Closing: |
January 2022 |
Investor: |
REKOM Group A/S and Spritfabrikken Danmark ApS |
TC Advisory: |
Translution Capital acted as Financial Advisor to the selling shareholders of I Am Drinks ApS on the trade sale of the company |
Transaction Size: |
EUR 11m |
Company Name: |
Diok Real Estate AG |
Closing: |
December 2021 |
Investor: |
Collector Bank |
TC Advisory: |
Translution Capital acted as Financial Advisor to Diok Real Estate AG securing a funding package of EUR 11 million |
Transaction Size: |
SEK 509m |
Company Name: |
CombiGene AB |
Closing: |
November 2021 |
Investor: |
Spark Therapeutics, a company within the Roche Group |
TC Advisory: |
Translution Capital acted as Financial Advisor to CombiGene AB (publ.) in a deal securing a total funding package of up to SEK 509 million |
Transaction Size: |
SEK 44m |
Company Name: |
Expres2ion Biotech |
Closing: |
October 2021 |
Investor: |
Private and institutional investors |
TC Advisory: |
Translution Capital acted as Financial Advisor to Expres2ion Biotechnologies (publ.) in a new issue to private and institutional investors |
Transaction Size: |
Non-disclosed |
Company Name: |
CRisk Software ApS |
Closing: |
September 2021 |
Investor: |
Brady Technologies Limited, backed by private equity firm, Hanover Investors |
TC Advisory: |
Translution Capital acted as Financial Advisor to the selling shareholders of CRisk Software ApS on the trade sale of the company |
Transaction Size: |
SEK 308m |
Company Name: |
Allarity Therapeutics A/S |
Closing: |
August 2021 |
Investor: |
Broad range of investors |
TC Advisory: |
Translution Capital acted as Financial Advisor to Allarity Therapeutics A/S (Publ.) in a secured rights issue |
Transaction Size: |
SEK 150m |
Company Name: |
Biosergen AB |
Closing: |
June 2021 |
Investor: |
Private and institutional investors |
TC Advisory: |
Translution Capital acted as Financial Advisor to Biosergen AB in their IPO to private and institutional investors |
Transaction Size: |
Non-disclosed |
Company Name: |
Bawat A/S |
Closing: |
June 2021 |
Investor: |
Institutional and HNI investors |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to Bawat A/S in relation to their fund raise led by selected institutional and HNI investors |
Transaction Size: |
SEK 39m |
Company Name: |
Expres2ion Biotech |
Closing: |
May 2021 |
Investor: |
Private and institutional investors |
TC Advisory: |
Translution Capital acted as Financial Advisor to Expres2ion Biotechnologies (publ.) in a new issue to private and institutional investors |
Transaction Size: |
DKK 180m |
Company Name: |
Medtrace Pharma A/S |
Closing: |
May 2021 |
Investor: |
ATP, BankInvest and Swisscanto |
TC Advisory: |
Translution Capital acted as Financial Advisor to Medtrace Pharma A/S in relation to their capital raise led by ATP, BankInvest and Swisscanto |
Transaction Size: |
Non-disclosed |
Company Name: |
Lamor Corporation AB |
Closing: |
April 2021 |
Investor: |
Institutional investors |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to Lamor Corporation AB in relation to their fund raise led by selected institutional investors |
Transaction Size: |
DKK 150m |
Company Name: |
Plant Protein Venture |
Closing: |
March 2021 |
Lenders: |
Institutional investors |
TC Advisory: |
Translution Capital acted as Financial Advisor together with Nordic Investment Partners to secure total project financing |
Transaction Size: |
EUR 3m |
Company Name: |
Akvila Cutlery Oy |
Closing: |
February 2021 |
Lenders: |
Institutional investors |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to Akvila Cutlery Oy in securing EUR 3m in debt financing |
Transaction Size: |
Non-disclosed |
Company Name: |
Bizbrains |
Closing: |
January 2021 |
Investor: |
VækstPartner Kapital |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to Bizbrains in relation to the sale of a minority stake to VækstPartner Kapital |
Transaction Size: |
SEK 216m |
Company Name: |
Expres2ion Biotech |
Closing: |
November 2020 |
Investor: |
NYIP |
TC Advisory: |
Translution Capital acted as Financial Advisor to Expres2ion Biotechnologies (publ.) in a fully secured rights issue, with a directed issue to selected institutional investors |
Transaction Size: |
Non-disclosed |
Company Name: |
Sigma Estimates |
Closing: |
October 2020 |
Acquirer: |
EG A/S |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to the owners of Sigma Estimates in relation to a trade sale of the company to EG |
Transaction Size: |
USD 182m |
Company Name: |
Margins Group |
Closing: |
August 2020 |
Investor: |
Institutional investors |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to the owners of Margins Group on a USD 182m refinancing facility led by Institutional investors |
Transaction Size: |
DKK 10m |
Company Name: |
Scape Technologies |
Closing: |
May 2020 |
Investor: |
Institutional investors |
TC Advisory: |
Translution Capital advised the Danish manufacturer of industrial robots, Scape Technologies, securing a temporary loan facility |
Transaction Size: |
SEK 30m |
Company Name: |
Endomines |
Closing: |
April 2020 |
Lenders: |
Institutional investors & selected HNI’s |
TC Advisory: |
Translution Capital acted as Financial Advisor to Endomines in a short-term loan facility from Institutional investors and selected HNI’s |
Transaction Size: |
DKK 12m |
Company Name: |
FluoGuide |
Closing: |
January 2020 |
Investor: |
Institutional investors & selected HNI’s |
TC Advisory: |
Translution Capital acted as Financial Advisor to FluoGuide (Publ.) in a directed share issue to institutional investors and selected HNI’s |
Transaction Size: |
EUR 9.3m |
Company Name: |
Tamigo |
Closing: |
December 2019 |
Investor: |
Viking Ventures |
TC Advisory: |
Translution Capital acted as sole Financial Advisor to Tamigo in relation to the sale of minority stakes combined with a share issue to Viking Venture |
Transaction Size: |
SEK 7m |
Company Name: |
CombiGene |
Closing: |
November 2019 |
Investor: |
Institutional investors |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to CombiGene, the listed Swedish gene therapy company in the bridge financing by Institutional investors |
Transaction Size: |
SEK 20m |
Company Name: |
CLS |
Closing: |
June 2019 |
Investor: |
Institutional investors |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to CLS, the listed Swedish cancer ablation company in the bridge financing by Institutional investors |
Transaction Size: |
NOK 42m |
Company Name: |
5th Planet Games |
Closing: |
March 2019 |
Investor: |
Institutional investors |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to 5th Planet Games in relation to the directed issue |
Transaction Size: |
SEK 36m |
Company Name: |
Expres2ion Biotech |
Closing: |
March 2019 |
Investor: |
Institutional investors |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to Nasdaq First North company, Expres2ion Biotechnologies in the directed issue to Institutional investors |
Transaction Size: |
Non-disclosed |
Company Name: |
Conscia Danmark A/S |
Closing: |
March 2019 |
Acquirer: |
NA |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to the owners of Conscia Danmark A/S in relation to a trade sale of the company |
Transaction Size: |
Non-disclosed |
Company Name: |
DCR Solutions |
Closing: |
December 2018 |
Investor: |
KMD Ventures and a consortium of Business Angels |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to DCR Solutions in relation to the capital raise led by KMD Ventures and a consortium of Business Angels |
Transaction Size: |
USD 8.5m |
Company Name: |
Evaxion |
Closing: |
November 2018 |
Investor: |
Indonesian investor and 9 Danish Family Offices and Business angels |
TC Advisory: |
Translution Capital acted as Sole Advisor to Evaxion in relation to the capital raise led by an Indonesian investor and 9 Danish Family Offices and Business Angels |
Transaction Size: |
Non-disclosed |
Company Name: |
Ordrestyring.dk |
Closing: |
August 2018 |
Acquirer: |
Adelis Equity Partners |
TC Advisory: |
Translution Capital acted as Financial Advisor to the owners of Ordrestyring.dk in relation to a majority sale of the company to Adelis Equity Partners |
Transaction Size: |
Non-disclosed |
Company Name: |
Nordic Impact Funds |
Closing: |
June 2018 |
Investor: |
Institutional investors |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to Nordic Impact Funds in the close of their first fund |
Transaction Size: |
DKK 35m |
Company Name: |
EuroInvestor |
Closing: |
March 2018 |
Investor: |
High Networth Individuals |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to EuroInvestor in the fund-raising process led by several High Networth Individuals |
Transaction Size: |
Non-disclosed |
Company Name: |
Rødbillet.dk |
Closing: |
June 2017 |
Acquirer: |
Flixbus |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to Rødbillet.dk in relation to the sale of 100% of the company to Flixbus, the German bus transportation company |
Transaction Size: |
SEK 35m |
Company Name: |
Saniona |
Closing: |
May 2017 |
Investor: |
Institutional investors |
TC Advisory: |
Translution Capital acted as Joint Bookrunner in the directed issue in Saniona on Nasdaq First North, led by Institutional investors |
Transaction Size: |
Non-disclosed |
Company Name: |
Shobr |
Closing: |
October 2016 |
Investor: |
A consortium of Danish Business Angels |
TC Advisory: |
Translution Capital acted as Sole Financial Advisor to Shobr in relation to the capital raise led by a consortium of Danish Business Angels |